These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 29786690)

  • 21. Efficient incorporation of HLA class II onto human immunodeficiency virus type 1 requires envelope glycoprotein packaging.
    Poon DT; Coren LV; Ott DE
    J Virol; 2000 Apr; 74(8):3918-23. PubMed ID: 10729169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of the LWYIK motif located in the human immunodeficiency virus type 1 transmembrane gp41 protein as a distinct determinant for viral infection.
    Chen SS; Yang P; Ke PY; Li HF; Chan WE; Chang DK; Chuang CK; Tsai Y; Huang SC
    J Virol; 2009 Jan; 83(2):870-83. PubMed ID: 18987155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env.
    Lenardo MJ; Angleman SB; Bounkeua V; Dimas J; Duvall MG; Graubard MB; Hornung F; Selkirk MC; Speirs CK; Trageser C; Orenstein JO; Bolton DL
    J Virol; 2002 May; 76(10):5082-93. PubMed ID: 11967324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of an envelope mutant of HIV-1 that interferes with viral infectivity.
    Chen SS; Ferrante AA; Terwilliger EF
    Virology; 1996 Dec; 226(2):260-8. PubMed ID: 8955046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity.
    Chazal N; Singer G; Aiken C; Hammarskjöld ML; Rekosh D
    J Virol; 2001 Apr; 75(8):4014-8. PubMed ID: 11264394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of virion surface gp120 density on infection by HIV-1 and viral production by infected cells.
    Bachrach E; Dreja H; Lin YL; Mettling C; Pinet V; Corbeau P; Piechaczyk M
    Virology; 2005 Feb; 332(1):418-29. PubMed ID: 15661172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of Env content in virions of simian immunodeficiency virus: correlation with cell surface expression and virion infectivity.
    Yuste E; Reeves JD; Doms RW; Desrosiers RC
    J Virol; 2004 Jul; 78(13):6775-85. PubMed ID: 15194752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic Correlates of HIV-1 Macrophage Tropism.
    Arrildt KT; LaBranche CC; Joseph SB; Dukhovlinova EN; Graham WD; Ping LH; Schnell G; Sturdevant CB; Kincer LP; Mallewa M; Heyderman RS; Rie AV; Cohen MS; Spudich S; Price RW; Montefiori DC; Swanstrom R
    J Virol; 2015 Nov; 89(22):11294-311. PubMed ID: 26339058
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Acylguanidine-Based Inhibitor of HIV-1.
    Mwimanzi P; Tietjen I; Miller SC; Shahid A; Cobarrubias K; Kinloch NN; Baraki B; Richard J; Finzi A; Fedida D; Brumme ZL; Brockman MA
    J Virol; 2016 Oct; 90(20):9495-508. PubMed ID: 27512074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting cell-free HIV and virally-infected cells with anti-HLA-DR immunoliposomes containing amphotericin B.
    Bestman-Smith J; Désormeaux A; Tremblay MJ; Bergeron MG
    AIDS; 2000 Nov; 14(16):2457-65. PubMed ID: 11101055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.
    Takashima K; Miyake H; Furuta RA; Fujisawa JI; Iizawa Y; Kanzaki N; Shiraishi M; Okonogi K; Baba M
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3538-43. PubMed ID: 11709336
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dense Array of Spikes on HIV-1 Virion Particles.
    Stano A; Leaman DP; Kim AS; Zhang L; Autin L; Ingale J; Gift SK; Truong J; Wyatt RT; Olson AJ; Zwick MB
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of human immunodeficiency virus type 1 (HIV-1) pseudoviruses using linear HIV-1 envelope expression cassettes.
    Beels D; Heyndrickx L; Vereecken K; Vermoesen T; Michiels L; Vanham G; Kestens L
    J Virol Methods; 2008 Jan; 147(1):99-107. PubMed ID: 17904649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Antiviral Activity of the Cellular Glycoprotein LGALS3BP/90K Is Species Specific.
    Lodermeyer V; Ssebyatika G; Passos V; Ponnurangam A; Malassa A; Ewald E; Stürzel CM; Kirchhoff F; Rotger M; Falk CS; Telenti A; Krey T; Goffinet C
    J Virol; 2018 Jul; 92(14):. PubMed ID: 29743357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 gag polyprotein rescues HLA-DR intracellular transport in a human CD4+ cell line.
    Gluschankof P; Suzan M
    Virology; 2002 Aug; 300(1):160-9. PubMed ID: 12202216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dominant-negative effect of hetero-oligomerization on the function of the human immunodeficiency virus type 1 envelope glycoprotein complex.
    Herrera C; Klasse PJ; Kibler CW; Michael E; Moore JP; Beddows S
    Virology; 2006 Jul; 351(1):121-32. PubMed ID: 16616288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and biological characterization of recombinant HIV type 1 with Env derived from long-term nonprogressor (LTNP) viruses.
    Antoni S; Walz N; Landersz M; Humbert M; Seidl C; Dittmar MT; Dietrich U
    AIDS Res Hum Retroviruses; 2007 Nov; 23(11):1377-86. PubMed ID: 18184081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tail-interacting protein TIP47 is a connector between Gag and Env and is required for Env incorporation into HIV-1 virions.
    Lopez-Vergès S; Camus G; Blot G; Beauvoir R; Benarous R; Berlioz-Torrent C
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14947-52. PubMed ID: 17003132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wild-type-like viral replication potential of human immunodeficiency virus type 1 envelope mutants lacking palmitoylation signals.
    Chan WE; Lin HH; Chen SS
    J Virol; 2005 Jul; 79(13):8374-87. PubMed ID: 15956582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition.
    Prentice HA; Tomaras GD; Geraghty DE; Apps R; Fong Y; Ehrenberg PK; Rolland M; Kijak GH; Krebs SJ; Nelson W; DeCamp A; Shen X; Yates NL; Zolla-Pazner S; Nitayaphan S; Rerks-Ngarm S; Kaewkungwal J; Pitisuttithum P; Ferrari G; McElrath MJ; Montefiori DC; Bailer RT; Koup RA; O'Connell RJ; Robb ML; Michael NL; Gilbert PB; Kim JH; Thomas R
    Sci Transl Med; 2015 Jul; 7(296):296ra112. PubMed ID: 26180102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.